Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 147.3M | 142.6M | 143.0M | 136.3M |
Cost of revenue | 106.7M | 100.0M | 103.3M | 97.4M |
Gross profit | 40.6M | 42.6M | 39.7M | 38.8M |
Operating expense | ||||
Research & development | 3.2M | 4.6M | 3.0M | 2.8M |
Selling general and admin | 21.6M | 22.1M | 21.6M | 20.8M |
Other operating expenses | — | — | — | — |
Operating income | 15.7M | 15.9M | 15.1M | 15.2M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 1.1M | 2.5M | 1.4M | 1.2M |
Other income expense | — | — | — | -121K |
Pretax income | 14.7M | 14.3M | 13.7M | 13.8M |
Tax provision | 2.9M | 2.3M | 3.3M | 3.0M |
Net income | 11.6M | 12.3M | 10.3M | 10.8M |
Basic EPS | 0.2 | — | 0.2 | 0.2 |
Diluted EPS | 0.2 | — | 0.2 | 0.2 |
Basic average shares | 49.1M | — | 49.1M | 49.1M |
Diluted average shares | 49.1M | — | 49.1M | 49.1M |
EBITDA | 21.0M | 22.2M | 20.3M | 20.4M |
Net income from continuing op. | 11.6M | 12.3M | 10.3M | 10.7M |
Minority interests | -2.2M | -1.7M | -1.9M | -1.6M |
Preferred stock dividends | — | — | — | — |